BioNTech SE (BNTX) EPS (Basic) (2018 - 2025)
BioNTech SE's (BNTX) quarterly EPS (Basic) came in at -$0.58 in Q4 2025, down 155.41% year-on-year from $1.04 in Q4 2024, and down 284.1% quarter-over-quarter from $0.31 in Q3 2025.
BioNTech SE (BNTX) EPS (Basic) (2018 - 2025) Analysis & Trends
BioNTech SE has disclosed EPS (Basic) across 8 years of filings, most recently posting -$0.58 for Q4 2025.
- EPS (Basic) for Q4 2025 came in at -$0.58, down 155.41% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.86 (down 100.0% YoY), and the FY2025 annual result was -$3.73, down 25.94% from the prior year.
- EPS (Basic) came in at -$0.58 for Q4 2025 at BioNTech SE, down from $0.31 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $150102.0 in Q3 2023 to a low of -$3.23 in Q2 2024.
- The 5-year median for EPS (Basic) is $0.31 (2025), against an average of $19707.3.
- Across the five-year window, EPS (Basic) jumped 128804137.05% in 2022 and plunged 322.16% in 2024, its largest moves.
- BioNTech SE's EPS (Basic) stood at $0.0 in 2021, then surged by 128804137.05% to $16.71 in 2022, then slumped by 88.61% to $1.9 in 2023, then tumbled by 45.15% to $1.04 in 2024, then tumbled by 155.41% to -$0.58 in 2025.
- The last three EPS (Basic) figures came in at -$0.58 (Q4 2025), $0.31 (Q3 2025), and -$1.68 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | -0.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.58 |
| Sep 30, 2025 | 0.31 |
| Jun 30, 2025 | -1.68 |
| Mar 31, 2025 | -1.91 |
| Dec 31, 2024 | 1.04 |
| Sep 30, 2024 | 145,487.80 |
| Jun 30, 2024 | -3.23 |
| Mar 31, 2024 | -1.27 |
| Dec 31, 2023 | 1.90 |
| Sep 30, 2023 | 150,102.04 |
| Jun 30, 2023 | -0.77 |
| Mar 31, 2023 | 2.02 |
| Dec 31, 2022 | 16.71 |
| Jun 30, 2022 | 6.73 |
| Dec 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.00 |
| Mar 31, 2020 | 0.00 |
| Dec 31, 2019 | -1.59 |
| Sep 30, 2019 | 0.16 |
| Dec 31, 2018 | 0.24 |